Skip to main content

Peer Review reports

From: Cost of illness of HER2-positive and metastatic and recurrent HER2-positive breast cancer – a Danish register-based study from 2005 to 2016

Original Submission
15 Sep 2021 Submitted Original manuscript
10 Nov 2021 Reviewed Reviewer Report
7 Dec 2021 Reviewed Reviewer Report - Christoffer Bugge
6 Mar 2022 Author responded Author comments - Jens Olsen
Resubmission - Version 2
6 Mar 2022 Submitted Manuscript version 2
9 Mar 2022 Author responded Author comments - Jens Olsen
Resubmission - Version 3
9 Mar 2022 Submitted Manuscript version 3
24 Mar 2022 Reviewed Reviewer Report
5 Apr 2022 Reviewed Reviewer Report - Christoffer Bugge
16 May 2022 Author responded Author comments - Jens Olsen
Resubmission - Version 4
16 May 2022 Submitted Manuscript version 4
Publishing
23 May 2022 Editorially accepted
4 Jun 2022 Article published 10.1186/s12913-022-08143-7

You can find further information about peer review here.

Back to article page